 |
||
 |
|
|
2004 2003200220012000 |
||
|
||
|
Wagner to Become CEO of ProVation
Medical Minneapolis, MN- ProVation Medical yesterday announced the appointment of Mark T. Wagner as chief executive officer. Wagner will join the company on Dec 1. Wagner was formerly chairman and chief executive officer of Survivalink Corp., Minneapolis-based developers of automatic external defibrillators. Wagner last month completed the successful sale of Survivalink to Cardiac Science. He served jointly as president and chief executive officer of Altiva Corp. Wagner also serves on the boards of Altiva and Data Sciences. In addition to his proven track record with early stage companies, Wagner previously held key positions with international divisions of Nellcor Puritan Bennett and GE Medical Systems. "Wagner brings to ProVation a wealth of experience in driving the adoption of new technologies into the healthcare marketplace," says Rodney Wolford, chairman of ProVation. "We are pleased to have attracted an individual of his caliber to lead this company." "I am impressed by the depth of ProVation's Provalent product line and the high level of satisfaction among its large user base of physicians," says Wagner. "ProVation's attention to detail in constructing a solution that physicians actually use was immediately appealing. I am pleased to join a company that is committed to helping hospitals and medical specialists work together so effectively. Contact: Arvind Subramanian ProVation Medical 612.313.1500 Don Mundie Delta Capital Management LLC 901-755-0949 yearwood@deltacapital.com |
|
